» Articles » PMID: 32987841

Indocyanine Green-Enhanced Colorectal Surgery-between Being Superfluous and Being a Game-Changer

Overview
Specialty Radiology
Date 2020 Sep 29
PMID 32987841
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Nowadays, surgical innovations incorporate new technological conquests and must be validated by evidence-based medicine. The use of augmented reality-assisted indocyanine green (ICG) fluorescence has generated a myriad of intraoperative applications such as demonstration of key anatomical landmarks, sentinel lymph nodes, and real-time assessment of local blood flow. This paper presents a systematic review of the clinical evidence regarding the applications of ICG near-infrared (NIR) fluorescence in colorectal surgery. After we removed duplicate publications and screened for eligibility, a total of 36 articles were evaluated: 23 on perfusion assessment, 10 on lymph node mapping, and 3 on intraoperative identification of ureters. Lack of homogenous studies, low statistical power, and confounding evidence were found to be common amongst publications supporting the use of ICG in colorectal surgery, raising concerns over this seductive technique's cost efficiency and redundancy. The compiled data showed that ICG NIR fluorescence may be a game-changer in particular situations, as proven for low colorectal anastomosis or lateral pelvic lymph node dissection, but it remains controversial for routine use and sentinel lymph node assessment. Further randomized studies are needed to confirm these conclusions. Future research directions include tumor-targeted fluorescence imaging and digital software for quantitative evaluation of fluorescence.

Citing Articles

Fluorescence-guided tumor visualization of colorectal cancer using tumor-initiating probe yellow in preclinical models.

Kim S, Kim J, Kim H, Chang Y, Kwon H, Lee J Sci Rep. 2024; 14(1):26946.

PMID: 39505985 PMC: 11542034. DOI: 10.1038/s41598-024-76312-1.


Progress of fluorescence imaging in lymph node dissection surgery for prostate and bladder cancer.

Xu M, Li P, Wei J, Yan P, Zhang Y, Guo X Front Oncol. 2024; 14:1395284.

PMID: 39429471 PMC: 11486700. DOI: 10.3389/fonc.2024.1395284.


Efficacy and Safety of Fluorescence-Guided Surgery Compared to Conventional Surgery in the Management of Colorectal Cancer: A Systematic Review and Meta-Analysis.

Fadel M, Zonoobi E, Rodriguez-Luna M, Mishima K, Ris F, Diana M Cancers (Basel). 2024; 16(19).

PMID: 39409997 PMC: 11476237. DOI: 10.3390/cancers16193377.


Indocyanine Green (ICG) Fluorescence in the Assessment of Vascularity of Anastomotic Margins in Colorectal Surgery in a Lower Middle-Income Country (LMIC) Hospital.

Lim M, Lopez M, Onglao M, Monroy 3rd H, Sacdalan M Acta Med Philipp. 2024; 58(16):8-13.

PMID: 39399367 PMC: 11467550. DOI: 10.47895/amp.v58i16.7057.


Near-infrared indocyanine green angiography in recognizing bowel ischemia in emergency surgery: game changer or overrated?.

Christofi A, Traska T, Dimitroulis D Innov Surg Sci. 2024; 9(3):113-121.

PMID: 39309192 PMC: 11415940. DOI: 10.1515/iss-2024-0013.


References
1.
Jafari M, Lee K, Halabi W, Mills S, Carmichael J, Stamos M . The use of indocyanine green fluorescence to assess anastomotic perfusion during robotic assisted laparoscopic rectal surgery. Surg Endosc. 2013; 27(8):3003-8. DOI: 10.1007/s00464-013-2832-8. View

2.
Su H, Wu H, Bao M, Luo S, Wang X, Zhao C . Indocyanine green fluorescence imaging to assess bowel perfusion during totally laparoscopic surgery for colon cancer. BMC Surg. 2020; 20(1):102. PMC: 7218821. DOI: 10.1186/s12893-020-00745-4. View

3.
Degett T, Andersen H, Gogenur I . Indocyanine green fluorescence angiography for intraoperative assessment of gastrointestinal anastomotic perfusion: a systematic review of clinical trials. Langenbecks Arch Surg. 2016; 401(6):767-75. DOI: 10.1007/s00423-016-1400-9. View

4.
Mizrahi I, Abu-Gazala M, Rickles A, Fernandez L, Petrucci A, Wolf J . Indocyanine green fluorescence angiography during low anterior resection for low rectal cancer: results of a comparative cohort study. Tech Coloproctol. 2018; 22(7):535-540. DOI: 10.1007/s10151-018-1832-z. View

5.
Bockelman C, Engelmann B, Kaprio T, Hansen T, Glimelius B . Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature. Acta Oncol. 2014; 54(1):5-16. DOI: 10.3109/0284186X.2014.975839. View